Lucid Diagnostics Inc

NAS:LUCD (USA)  
$ 0.76 -0.0108 (-1.39%) 11:09 PM EST
At Loss
Market Cap:
$ 45.35M
Enterprise V:
$ 99.85M
Volume:
189.04K
Avg Vol (2M):
547.27K
Trade In:
Volume:
189.04K
At Loss
Avg Vol (2M):
547.27K

Business Description

Lucid Diagnostics Inc
NAICS : 325413 SIC : 3845
ISIN : US54948X1090
Description
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Name Current Vs Industry Vs History
Cash-To-Debt 1.11
Equity-to-Asset 0.28
Debt-to-Equity 2.06
Debt-to-EBITDA -0.3
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -16.45
Distress
Grey
Safe
Beneish M-Score 1.48
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 26.09
9-Day RSI 27.68
14-Day RSI 31.87
6-1 Month Momentum % 24.77
12-1 Month Momentum % -28.64

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.18
Quick Ratio 1.14
Cash Ratio 1.02
Days Inventory 25.19
Days Sales Outstanding 5.47
Days Payable 58.61

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4.6
Shareholder Yield % -6.3

Financials (Next Earnings Date:2025-03-26 Est.)

LUCD's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:LUCD

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Lucid Diagnostics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 4.189
EPS (TTM) ($) -1.13
Beta 1.39
Volatility % 44.98
14-Day RSI 31.87
14-Day ATR ($) 0.051618
20-Day SMA ($) 0.847525
12-1 Month Momentum % -28.64
52-Week Range ($) 0.6301 - 1.58
Shares Outstanding (Mil) 59.34

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Lucid Diagnostics Inc Filings

Filing Date Document Date Form
No Filing Data

Lucid Diagnostics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Lucid Diagnostics Inc Frequently Asked Questions

What is Lucid Diagnostics Inc(LUCD)'s stock price today?
The current price of LUCD is $0.76. The 52 week high of LUCD is $1.58 and 52 week low is $0.63.
When is next earnings date of Lucid Diagnostics Inc(LUCD)?
The next earnings date of Lucid Diagnostics Inc(LUCD) is 2025-03-26 Est..
Does Lucid Diagnostics Inc(LUCD) pay dividends? If so, how much?
Lucid Diagnostics Inc(LUCD) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1